3D Systems Corp. (DDD) Lacked Proper Internal Controls Over Financial Reporting   Throughout the class period, 3D Systems attested to the accuracy of its financial reporting and disclosure controls and

Emergent BioSolutions Inc. (EBS) Misled Investors Regarding its Business Operations In response to the COVID-19 pandemic, Emergent signed deals with Johnson & Johnson and AstraZeneca worth a combined $875 million

Acadia Pharmaceuticals Inc. (ACAD) Misled Shareholders Regarding the Viability of Pimavanserin for Dementia-Related Psychosis       In April 2016, the FDA approved pimavanserin for the treatment of hallucinations and delusions associated

Arcimoto Inc. (FUV) Misled Investors Regarding its Business Operations Arcimoto stated in press releases from 2018 to 2020 that they had received 400 preorders for their Fun Utility Vehicle.  Arcimoto

Clover Health Investment, Corp.  (CLOV) Misled Shareholders Ahead of Going Public            On October 6, 2020, the Company issued a press release announcing plans to become a publicly traded company

LifeMD, Inc. (LFMD) Misled Investors Regarding its Business Operations Throughout the class period, defendants made false and/or misleading statements regarding its business.  Specifically, defendants failed to disclose that: (1) many

Intrusion Inc. (INTZ) Misled Investors Regarding its Business Operations Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations,

Franklin Wireless Corp. (FKWL) Failed to Disclose its Hotspot Devices Suffered from Battery Issues     On April 1, 2021, Franklin stated that it “ha[d] been notified of reports of battery